Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Insider Actions Highlight 3 Undervalued Small Caps In Global Market

In This Article:

In the current global market landscape, small-cap stocks are navigating a challenging environment characterized by declining consumer confidence and persistent inflation concerns, as seen in recent economic indicators. While major indices like the S&P 600 have faced pressure, this environment can often highlight opportunities for discerning investors who focus on companies with strong fundamentals and strategic insider actions.

Top 10 Undervalued Small Caps With Insider Buying Globally

Name

PE

PS

Discount to Fair Value

Value Rating

Bytes Technology Group

19.5x

5.0x

23.27%

★★★★★★

Macfarlane Group

10.4x

0.6x

40.95%

★★★★★★

Speedy Hire

NA

0.2x

26.26%

★★★★★☆

Hong Leong Asia

9.4x

0.2x

43.95%

★★★★☆☆

4imprint Group

16.4x

1.3x

34.70%

★★★★☆☆

Gamma Communications

22.6x

2.3x

35.57%

★★★★☆☆

Franchise Brands

38.0x

2.0x

27.04%

★★★★☆☆

Optima Health

NA

1.5x

44.96%

★★★★☆☆

Calfrac Well Services

11.3x

0.2x

-28.93%

★★★☆☆☆

Saturn Oil & Gas

1.7x

0.5x

-43.80%

★★★☆☆☆

Click here to see the full list of 116 stocks from our Undervalued Global Small Caps With Insider Buying screener.

Let's uncover some gems from our specialized screener.

Integral Diagnostics

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Integral Diagnostics operates diagnostic imaging facilities, providing medical imaging services across Australia and New Zealand, with a market cap of A$741.29 million.

Operations: Revenue is primarily generated from diagnostic imaging facilities, with the latest reported revenue at A$491.32 million. The gross profit margin has shown a declining trend, reaching 31.66% in the most recent period. Operating expenses and non-operating expenses have significantly impacted net income, which was recorded at A$5.66 million recently after a period of negative net income figures.

PE: 150.3x

Integral Diagnostics, a smaller company in the healthcare sector, recently reported half-year sales of A$252.87 million, up from A$231.25 million the previous year. Despite this growth, they faced a net loss of A$0.396 million compared to a larger loss previously. Insider confidence is evident with recent insider purchases over the last few months. However, financial challenges remain as interest payments aren't fully covered by earnings and funding relies on external borrowing sources only.

ASX:IDX Share price vs Value as at Mar 2025
ASX:IDX Share price vs Value as at Mar 2025

Pantoro

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Pantoro is a gold exploration and production company primarily focused on its Norseman Gold Project, with a market capitalization of A$0.13 billion.